Zhong Xi Zoë, Cao Qi, Sun Xue, Dong Xian-Ping
Department of Physiology and Biophysics, Dalhousie University, Halifax, B3H 4R2, Nova Scotia, Canada.
J Physiol. 2016 Aug 1;594(15):4253-66. doi: 10.1113/JP271893. Epub 2016 May 29.
SLC17A9 proteins function as a lysosomal ATP transporter responsible for lysosomal ATP accumulation. P2X4 receptors act as lysosomal ion channels activated by luminal ATP. SLC17A9-mediated ATP transport across the lysosomal membrane is suppressed by Bafilomycin A1, the V-ATPase inhibitor. SLC17A9 mainly uses voltage gradient but not pH gradient generated by the V-ATPase as the driving force to transport ATP into the lysosome to activate P2X4.
The lysosome contains abundant ATP which plays important roles in lysosome functions and in cell signalling. Recently, solute carrier family 17 member 9 (SLC17A9, also known as VNUT for vesicular nucleotide transporter) proteins were suggested to function as a lysosomal ATP transporter responsible for lysosomal ATP accumulation, and P2X4 receptors were suggested to be lysosomal ion channels that are activated by luminal ATP. However, the molecular mechanism of SLC17A9 transporting ATP and the regulatory mechanism of lysosomal P2X4 are largely unknown. In this study, we report that SLC17A9-mediated ATP transport across lysosomal membranes is suppressed by Bafilomycin A1, the V-ATPase inhibitor. By measuring P2X4 activity, which is indicative of ATP transport across lysosomal membranes, we further demonstrated that SLC17A9 mainly uses voltage gradient but not pH gradient as the driving force to transport ATP into lysosomes. This study provides a molecular mechanism for lysosomal ATP transport mediated by SLC17A9. It also suggests a regulatory mechanism of lysosomal P2X4 by SLC17A9.
溶质载体家族17成员9(SLC17A9,也称为囊泡核苷酸转运体VNUT)蛋白作为一种溶酶体ATP转运体,负责溶酶体ATP的积累。P2X4受体作为溶酶体离子通道,由腔内ATP激活。V-ATP酶抑制剂巴弗洛霉素A1可抑制SLC17A9介导的ATP跨溶酶体膜转运。SLC17A9主要利用V-ATP酶产生的电压梯度而非pH梯度作为驱动力,将ATP转运至溶酶体以激活P2X4。
溶酶体含有丰富的ATP,其在溶酶体功能和细胞信号传导中发挥重要作用。最近,溶质载体家族17成员9(SLC17A9,也称为囊泡核苷酸转运体VNUT)蛋白被认为是一种负责溶酶体ATP积累的溶酶体ATP转运体,而P2X4受体被认为是由腔内ATP激活的溶酶体离子通道。然而,SLC17A9转运ATP的分子机制以及溶酶体P2X4的调节机制在很大程度上尚不清楚。在本研究中,我们报道V-ATP酶抑制剂巴弗洛霉素A1可抑制SLC17A9介导的ATP跨溶酶体膜转运。通过测量指示ATP跨溶酶体膜转运的P2X4活性,我们进一步证明SLC17A9主要利用电压梯度而非pH梯度作为驱动力,将ATP转运至溶酶体。本研究提供了SLC17A9介导的溶酶体ATP转运的分子机制。它还提示了SLC17A9对溶酶体P2X4的调节机制。